Hydralazine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Hydralazine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

HYDRALAZINE HYDROCHLORIDE DESCRIPTION


Hydralazine Hydrochloride





CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY




INDICATIONS & USAGE

INDICATIONS AND USAGE


CONTRAINDICATIONS

CONTRAINDICATIONS


WARNINGS

WARNINGS

PRECAUTIONS, Laboratory Tests

PRECAUTIONS

General





INFORMATION FOR PATIENTS

Information for Patients


LABORATORY TESTS

Laboratory Tests




DRUG INTERACTIONS

Drug/Drug Interactions


Drug/Food Interactions


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

Carcinogenesis, Mutagenesis, Impairment of Fertility



PREGNANCY

Pregnancy Category C



NURSING MOTHERS

Nursing Mothers


PEDIATRIC USE

Pediatric Use


HYDRALAZINE HYDROCHLORIDE ADVERSE REACTIONS

ADVERSE REACTIONS











OVERDOSAGE

OVERDOSAGE










DOSAGE & ADMINISTRATION

DOSAGE AND ADMINISTRATION





HOW SUPPLIED



























INACTIVE INGREDIENT

INACTIVE INGREDIENTS:

FD&C RED NO. 40

HYPROMELLOSE
ANHYDROUS LACTOSE
MINERAL OIL
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
STARCH, CORN
SODIUM LAURYL SULFATE
TITANIUM DIOXIDE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Hydralazine Hydrochloride

Hydralazine Hydrochloride

Hydralazine Hydrochloride

Hydralazine Hydrochloride TABLET, FILM COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-179(NDC:23155-002)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
HYDRALAZINE HYDROCHLORIDE HYDRALAZINE 25 mg

Inactive Ingredients

Ingredient Name Strength
FD&C RED NO. 40
HYPROMELLOSES
ANHYDROUS LACTOSE
Mineral Oil
cellulose, microcrystalline
MAGNESIUM STEARATE
STARCH, CORN
SODIUM LAURYL SULFATE
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
pink 8 mm HP;2 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-179-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA086242 2011-04-19


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.